Cellectar Biosciences, Inc. Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' EQUITY (Details 1) - shares	12 Months Ended
STOCKHOLDERS' EQUITY (Details 1) - shares	Dec. 31, 2017	Dec. 31, 2016
Number Of Shares Reserved For Future Issuance	13,704,648	12,321,724
Preferred Stock [Member]
Number Of Shares Reserved For Future Issuance	962,845	1,133,339
Warrant [Member]
Number Of Shares Reserved For Future Issuance	11,830,074	10,716,952
Stock options [Member]
Number Of Shares Reserved For Future Issuance	911,729	471,433